Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations

BACKGROUND: Drug-resistant epilepsy negatively impacts the quality of life and is associated with increased morbidity and mortality and high costs to the healthcare system. Cannabis-based treatments may be effective in reducing seizures in this population, but whether they are cost-effective is uncl...

Descripción completa

Detalles Bibliográficos
Autores principales: Elliott, Jesse, McCoy, Bláthnaid, Clifford, Tammy, Potter, Beth K., Skidmore, Becky, Wells, George A., Coyle, Doug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436234/
https://www.ncbi.nlm.nih.gov/pubmed/30917869
http://dx.doi.org/10.1186/s13643-019-0990-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436234/
https://www.ncbi.nlm.nih.gov/pubmed/30917869
http://dx.doi.org/10.1186/s13643-019-0990-z

Ejemplares similares